Sun Pharma gains as its arm launches AG version of Benicar, Benicar HCT, Azor and Tribenzor in US

27 Oct 2016 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 741.35, up by 1.80 points or 0.24% from its previous closing of Rs. 739.55 on the BSE.

The scrip opened at Rs. 744.90 and has touched a high and low of Rs. 744.90 and Rs. 737.55 respectively. So far 3,059 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 907.55 on 28-Oct-2015 and a 52 week low of Rs. 706.40 on 24-Nov-2015.

Last one week high and low of the scrip stood at Rs. 758.50 and Rs. 736.50 respectively. The current market cap of the company is Rs. 1,78,576.00 crore.

The promoters holding in the company stood at 54.97%, while Institutions and Non-Institutions held 33.34% and 11.68% respectively.

Sun Pharmaceutical Industries’ wholly owned subsidiary has launched the Authorized Generic (AG) versions for all strengths of Benicar, Benicar HCT, Azor and Tribenzor in US.

The pharma major has launched Olmesartan Medoxomil tablets - therapeutic equivalent of Daiichi Sankyo Inc.’s Benicar  (olmesartan medoxomil) tablets; Olmesartan Medoxomil-Hydrochlorothiazide tablets - therapeutic equivalent of Daiichi Sankyo Inc.’s Benicar HCT  (olmesartan medoxomil-hydrochlorothiazide) tablets; Amlodipine Besylate-Olmesartan Medoxomil tablets - therapeutic equivalent of Daiichi Sankyo Inc.’s Azor (amlodipine and olmesartan medoxomil) tablets; and Amlodipine Besylate-Hydrochlorothiazide-Olmesartan Medoxomil tablets - therapeutic equivalent of Daiichi Sankyo Inc.’s Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide) tablets.

The launch is pursuant to a distribution and supply agreement between Sun Pharma’s wholly owned subsidiary and Daiichi Sankyo Inc., which grants the Sun Pharma subsidiary, exclusive rights to distribute these tablets in the US for a pre-determined period. Benicar, Benicar HCT, Azor and Tribenzor recorded US sales of approximately $2.5 billion for the 12 months ending August 31, 2016, as per IMS Health.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1806.90 20.65 (1.16%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×